EPS Basic: 9.05
Is the EPS basic high or low?
The EPS basic of 9.05 is in line with its 5-year average of 9.83, near the low end of its 5-year range (7.59–15.90).
8.58% above its 12-month average of 8.33.
DGX EPS Basic
Reported quarterly basic EPS; no daily interpolation.
DGX Average EPS Basic Chart
DGX Current vs Average EPS Basic Chart
DGX EPS Basic Metrics
EPS BASIC
9.05
EPS BASIC AVG TTM
8.33
EPS BASIC AVG 3Y
8.09
EPS BASIC AVG 5Y
9.83
EPS BASIC AVG 10Y
7.81
EPS BASIC AVG 15Y
5.99
EPS BASIC AVG 20Y
5.21
CURRENT VS TTM AVG
+8.58%
CURRENT VS 3Y AVG
+11.80%
CURRENT VS 5Y AVG
-7.90%
CURRENT VS 10Y AVG
+15.92%
CURRENT VS 15Y AVG
+50.98%
CURRENT VS 20Y AVG
+73.60%
EPS Basic Formula & Definition
EPS Basic is earnings per common share before the effect of potentially dilutive securities. It shows how much profit is attributable to each current common share.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
EPS Basic FAQ
- What is the EPS basic for Quest Diagnostics Incorporated (DGX)?
- The EPS basic for DGX stock is 9.05.
- Is Quest Diagnostics Incorporated's EPS basic high or low?
- The EPS basic of 9.05 is in line with its 5-year average of 9.83, near the low end of its 5-year range (7.59–15.90).
- What is the TTM average EPS basic for Quest Diagnostics Incorporated (DGX)?
- The TTM average EPS basic for DGX stock is 8.33.
- What is the 3Y average EPS basic for Quest Diagnostics Incorporated (DGX)?
- The 3Y average EPS basic for DGX stock is 8.09.
- What is the 5Y average EPS basic for Quest Diagnostics Incorporated (DGX)?
- The 5Y average EPS basic for DGX stock is 9.83.
- What is the 10Y average EPS basic for Quest Diagnostics Incorporated (DGX)?
- The 10Y average EPS basic for DGX stock is 7.81.
- What is the 15Y average EPS basic for Quest Diagnostics Incorporated (DGX)?
- The 15Y average EPS basic for DGX stock is 5.99.
- What is the 20Y average EPS basic for Quest Diagnostics Incorporated (DGX)?
- The 20Y average EPS basic for DGX stock is 5.21.
DGX EPS Basic History
| DATE | EPS BASIC |
|---|---|
| 2025-12-31 | 8.87 |
| 2024-12-31 | 7.80 |
| 2023-12-31 | 7.59 |
| 2022-12-31 | 8.12 |
| 2021-12-31 | 15.90 |
| 2020-12-31 | 10.68 |
| 2019-12-31 | 6.38 |
| 2018-12-31 | 5.41 |
| 2017-12-31 | 5.63 |
| 2016-12-31 | 4.58 |
| 2015-12-31 | 4.92 |
| 2014-12-31 | 3.83 |
| 2013-12-31 | 5.58 |
| 2012-12-31 | 3.49 |
| 2011-12-31 | 2.95 |
| 2010-12-31 | 4.08 |
| 2009-12-31 | 3.91 |
| 2008-12-31 | 2.99 |
| 2007-12-31 | 1.76 |
| 2006-12-31 | 2.98 |
| 2005-12-31 | 2.71 |
| 2004-12-31 | 2.45 |
| 2003-12-31 | 2.11 |
| 2002-12-31 | 1.67 |
| 2001-12-31 | 0.87 |
| 2000-12-31 | 0.57 |
| 1999-12-31 | -0.03 |
| 1998-12-31 | 0.23 |
| 1997-12-31 | -0.19 |
| 1996-12-31 | -5.33 |
Related Metrics
About Quest Diagnostics Incorporated
Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing. While primarily operating under the Quest Diagnostics brand, it also leverages specialized identities like AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum to reach a broad spectrum of clients. Its extensive client base includes patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and other direct healthcare entities. Delivery of these services is facilitated through a robust network comprising laboratories, patient service centers, in-office phlebotomists, call centers, and mobile health professionals including paramedics and nurses. Additionally, the company provides risk assessment services for the life insurance industry and offers comprehensive information technology solutions to healthcare organizations and clinicians.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- James E. Davis